TGA Approval

SOLU-MEDROL ACT-O-VIAL methylprednisolone (as sodium succinate) 125mg powder for injection and diluent in one vial (171992)

ARTG ID

171992

ARTG Name

SOLU-MEDROL ACT-O-VIAL methylprednisolone (as sodium succinate) 125mg powder for injection and diluent in one vial

Sponsor

Pfizer Australia Pty Ltd

ARTG Date

September 23, 2010

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

PFIZER AUSTRALIA PTY LTD

https://medical-cdn.nocode.com/drug_tga/c67ad6a433eba8cf52f0944a9b62240d.pdf

https://medical-cdn.nocode.com/drug_tga/2b57451d28ea03ce1ca5c7f513d331fa.pdf

Ingredient Name

methylprednisolone sodium succinate

Empowering clinical research with data-driven insights and AI-powered tools.

SOLU-MEDROL ACT-O-VIAL methylprednisolone (as sodium succinate) 125mg powder for injection and diluent in one vial (171992) - TGA 批准文号 | MedPath